Horace Atwood, MD
Plastic and Reconstructive Surgery · Fayetteville, ARNPI 1154419356
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $4,590 of the $6,008 with a category attached, or 76.4%. Mentor Worldwide LLC accounts for 96.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $4,866 and has fallen 98.6% since, to $69 in 2025.
Across 48 payments — averaging $125.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mentor Worldwide LLC$6K
- Integra Lifesciences Corporation$59
- KCI USA, Inc.$41
- Heron Therapeutics, Inc.$24
- AbbVie$22
- Pacira Pharmaceuticals Incorporated$21
- plus $43 from 3 others
What the payments were for
- Food & beverage$1,41824%
- Gifts$4,59076%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mentor Worldwide LLC | 39 | $5,798 |
| Integra Lifesciences Corporation | 2 | $59 |
| KCI USA, Inc. | 1 | $41 |
| Heron Therapeutics, Inc. | 1 | $24 |
| AbbVie | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Puma Biotechnology, Inc. | 1 | $17 |
| Mylan Institutional Inc. | 1 | $13 |
| Seagen Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic and reconstructive surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 20 | $290 |
| Gabapentin | 27 | $119 |
| Tramadol Hcl | 13 | $33 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Fayetteville
- Suzanne YeeLittle Rock$30K
- Eric WrightLittle Rock$9K
- Michael SpannLittle Rock$3K
- Adam NewmanMountain Home$2K
- Katarzyna KaniaSpringdale$2K
- Edward LoveLittle Rock$1K
- Melanie PrinceLittle Rock$795
- Lauren TilleyLittle Rock$71
- Gary PetrusN Little Rock$25
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.